Loveth Ayiama Eban, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1826 Woodlawn Dr Ste 3&4, Woodlawn, MD 21207 Phone: 410-800-2121 |
Genevieve Ifeanyichukwu, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6340 Security Blvd Ste B56, Woodlawn, MD 21207 Phone: 443-531-4264 |
Ms. Cynthia Denise Broadnax, MSN, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 6660 Security Blvd, Woodlawn, MD 21207 Phone: 443-380-0552 |
News Archive
Lightlake Therapeutics Inc., an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight and obese patients with Binge Eating Disorder, today announced that its patient testing stage of the Phase II clinical trials will start August 26th, 2011
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
Chronic conditions including obesity, cardiovascular disease, and cancer often begin with early, subtle changes in cellular metabolism.
Taiwan's legislative body the Yuan on Thursday approved the first reading of a proposed World Trade Organization amendment that would allow pharmaceutical companies to make lower-cost versions of generic antiretroviral drugs, as well as drugs for malaria and other diseases, to sell to developing countries, the CNA/Taipei Times reports.
› Verified 9 days ago